Cluster of symptomatic silicone oil droplets following intravitreal injections: A 1-year observational study

Autor: Sivertsen, Magne S., Lode, Heidrun Elisabeth, Tollefsrud Gjølberg, Torleif, Petrovski, Goran, Andersen, Jan Terje, Jørstad, Øystein Kalsnes, Moe, Morten Carsten

Publikováno v: Sivertsen, Magne S. Lode, Heidrun Elisabeth Tollefsrud Gjølberg, Torleif Petrovski, Goran Andersen, Jan Terje Jørstad, Øystein Kalsnes Moe, Morten Carsten . Cluster of symptomatic silicone oil droplets following intravitreal injections: A 1-year observational study. BMJ Open Ophthalmology. 2021, 6(1)
BMJ Open Ophthalmology

Externí odkaz: http://hdl.handle.net/10852/93338
https://www.duo.uio.no/bitstream/handle/10852/93338/1/e000764.full.pdf

Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients

Autor: Holter, Jan Cato, Pischke, Soeren, de Boer, Eline, Lind, Andreas, Jenum, Synne, Holten, Aleksander Rygh, Tonby, Kristian, Barratt-Due, Andreas, Sokolova, Marina, Schjalm, Camilla, Chaban, Viktoriia, Kolderup, Anette, Tran, Trung, Tollefsrud Gjølberg, Torleif, Skeie, Linda Gail, Hesstvedt, Liv, Ormåsen, Vidar, Fevang, Børre, Austad, Cathrine, Muller, Karl Erik, Fladeby, Cathrine, Holberg-Petersen, Mona, Halvorsen, Bente, Müller, Fredrik, Aukrust, Pål, Dudman, Susanne Gjeruldsen, Ueland, Thor, Andersen, Jan Terje, Lund-Johansen, Fridtjof, Heggelund, Lars, Dyrhol-Riise, Anne Ma, Mollnes, Tom Eirik

Publikováno v: Holter, J.C., Pischke, S.E., de Boer, E., Lind, A., Jenum, S., Holten, A.R. ... Mollnes, T.T. (2020). Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients. Proceedings of the National Academy of Sciences of the United States of America, 117(40), 25018-25025.

Externí odkaz: https://hdl.handle.net/10037/19791

Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients.

Autor: Holter JC; Department of Microbiology, Oslo University Hospital, 0424 Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway., Pischke SE; Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway; s.e.pischke@medisin.uio.no.; Division of Emergencies and Critical Care, Oslo University Hospital, 0424 Oslo, Norway.; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway., de Boer E; Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway.; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway., Lind A; Department of Microbiology, Oslo University Hospital, 0424 Oslo, Norway., Jenum S; Department of Infectious Diseases, Oslo University Hospital, 0424 Oslo, Norway., Holten AR; Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway.; Department of Acute Medicine, Oslo University Hospital, 0424 Oslo, Norway., Tonby K; Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway.; Department of Infectious Diseases, Oslo University Hospital, 0424 Oslo, Norway., Barratt-Due A; Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway.; Division of Emergencies and Critical Care, Oslo University Hospital, 0424 Oslo, Norway.; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway., Sokolova M; Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway.; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway., Schjalm C; Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway.; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway., Chaban V; Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway.; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway., Kolderup A; Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway.; Department of Pharmacology, University of Oslo, 0315 Oslo, Norway., Tran T; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway., Tollefsrud Gjølberg T; Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway.; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway.; Department of Pharmacology, University of Oslo, 0315 Oslo, Norway.; Department of Ophthalmology, Oslo University Hospital, 0424 Oslo, Norway., Skeie LG; Department of Infectious Diseases, Oslo University Hospital, 0424 Oslo, Norway., Hesstvedt L; Department of Infectious Diseases, Oslo University Hospital, 0424 Oslo, Norway., Ormåsen V; Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway.; Department of Infectious Diseases, Oslo University Hospital, 0424 Oslo, Norway., Fevang B; Research Institute of Internal Medicine, Oslo University Hospital, 0424 Oslo, Norway.; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, 0424 Oslo, Norway., Austad C; Department of Internal Medicine, Vestre Viken Hospital Trust, 3004 Drammen, Norway., Müller KE; Department of Internal Medicine, Vestre Viken Hospital Trust, 3004 Drammen, Norway.; Department of Clinical Science, Faculty of Medicine, University of Bergen, 5007 Bergen, Norway., Fladeby C; Department of Microbiology, Oslo University Hospital, 0424 Oslo, Norway., Holberg-Petersen M; Department of Microbiology, Oslo University Hospital, 0424 Oslo, Norway., Halvorsen B; Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway.; Research Institute of Internal Medicine, Oslo University Hospital, 0424 Oslo, Norway., Müller F; Department of Microbiology, Oslo University Hospital, 0424 Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway., Aukrust P; Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway.; Research Institute of Internal Medicine, Oslo University Hospital, 0424 Oslo, Norway.; Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, 0424 Oslo, Norway.; Faculty of Health Sciences, K.G. Jebsen Thrombosis Research and Expertise Center, University of Tromsø, 9037 Tromsø, Norway., Dudman S; Department of Microbiology, Oslo University Hospital, 0424 Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway., Ueland T; Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway.; Research Institute of Internal Medicine, Oslo University Hospital, 0424 Oslo, Norway.; Faculty of Health Sciences, K.G. Jebsen Thrombosis Research and Expertise Center, University of Tromsø, 9037 Tromsø, Norway., Andersen JT; Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway.; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway., Lund-Johansen F; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway.; ImmunoLingo Convergence Centre, University of Oslo, 0315 Oslo, Norway., Heggelund L; Department of Internal Medicine, Vestre Viken Hospital Trust, 3004 Drammen, Norway.; Department of Clinical Science, Faculty of Medicine, University of Bergen, 5007 Bergen, Norway., Dyrhol-Riise AM; Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway.; Department of Infectious Diseases, Oslo University Hospital, 0424 Oslo, Norway., Mollnes TE; Institute of Clinical Medicine, University of Oslo, 0315 Oslo, Norway.; Department of Immunology, Oslo University Hospital, 0424 Oslo, Norway.; Faculty of Health Sciences, K.G. Jebsen Thrombosis Research and Expertise Center, University of Tromsø, 9037 Tromsø, Norway.; Research Laboratory, Nordland Hospital Bodø, 8092 Bodø, Norway.; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology, 7491 Trondheim, Norway.

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2020 Oct 06; Vol. 117 (40), pp. 25018-25025. Date of Electronic Publication: 2020 Sep 17.